News Related to Magnetic Resonance Imaging

Related coverage linked through entity extraction aliases.

CervoMed's Neflamapimod Advances in DLB and ALS Clinical Programs

Apr 07, 2026

CervoMed presents new MRI data showing neflamapimod may reduce basal forebrain atrophy in dementia with Lewy bodies and finalizes Phase 3 trial design. The drug has also been selected for a UK-funded ALS platform trial, with first dosing expected by end of 2026.

Clinical Trial Costs and Phases: From Safety Testing to Market Approval

Mar 31, 2026

Clinical trials take 10-15 years and cost $1-2 billion from discovery to approval, progressing through four phases from safety testing to real-world monitoring. These studies face challenges including high costs, regulatory oversight, and participant recruitment while new technologies are transforming trial design. Illinois faces a shortage of Phase I clinical trial facilities despite local companies conducting over 50 such trials annually.

Doctors Implant Dopamine-Producing Stem Cells in Parkinson's Patients in Groundbreaking Trial

Mar 29, 2026

Doctors are implanting lab-grown stem cells into Parkinson's patients' brains in a groundbreaking clinical trial to restore dopamine production. The FDA has granted the Phase 1 REPLACE trial fast-track designation, testing iPSC-derived dopamine-producing cells in 12 patients with moderate to severe Parkinson's. Researchers will monitor participants for up to five years to assess motor function restoration and potential side effects.